Expresión de p53 y ki67 en piezas de prostatectomía radical. relación con los datos clínico-patológicos y supervivencia
Referencias (19)
- et al.
Protein expresion of p53, bcl-2, and ki67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer
Surgery
(1996) - et al.
Ki67 labeling indexin core needle biopsies independently predicts tumor-specific survival in prostate cancer
Human Pathol
(1998) - et al.
P53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate
J Urol
(1997) - et al.
Significance of familiar history of prostate cancer to traditional prognostic variables, genetics biomarkers, and recurrence after radical prostatectomy
Urology
(1998) - et al.
Perineal seedeing of prostate cancer as the only evidence of clinical recurrence 14 years after needle biopsy and radical prostatectomy: molecular correlation
Urology
(1998) - et al.
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?
J Urol
(1994) - et al.
Prognostic significance of bcl-2 in clinical localized prostate cancer
J Pathol
(1996) - et al.
Assessment of the biologic markers p53, ki67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery
Cancer
(1998) - et al.
Overexpression of p53 oncoprotein predicts local recurrence and long-term survival following radical prostatectomy
Proc Annu Meet Am Soc Clin Oncol
(1997)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2000 Asociación Española de Urología (AEU). Published by Elsevier España, S.L. All rights reserved.